These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38903594)

  • 1. The influence of the national drug price negotiation policy reform on the medical expenses of patients in Xuzhou City: an interrupted time series analysis.
    Qin Z; He M; Shen H; Liu S; Xu S; Chen L
    Front Public Health; 2024; 12():1381786. PubMed ID: 38903594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data.
    Li BX; Wang YQ; Yi YY; Zhou N; Lv ZX; Ma R; Li X; Yuan N
    BMC Public Health; 2024 May; 24(1):1309. PubMed ID: 38745323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of China's zero mark-up drug policy on drug cost of NCDs' outpatients: an interrupted time series analysis.
    Du J; Xie J; Qian Y; Wu M; Huang W; Yin J; Peng X; Deng D
    BMC Health Serv Res; 2021 Apr; 21(1):404. PubMed ID: 33926444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Critical Illness Insurance on the Burden of High-Cost Rural Residents in Central China: An Interrupted Time Series Study.
    Li L; Jiang J; Xiang L; Wang X; Zeng L; Zhong Z
    Int J Environ Res Public Health; 2019 Sep; 16(19):. PubMed ID: 31547215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of unifying urban and rural residents' medical insurance on the hospitalisation expenses of rural patients in eastern China: an interrupted time series analysis.
    Qin Z; Liu S; Zhou M; Chen L; Huang W; Shen L
    BMJ Open; 2023 May; 13(5):e067198. PubMed ID: 37230522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China.
    Lin T; Wu Z; Liu M; Wu X; Zhang X
    Int J Equity Health; 2020 Aug; 19(1):133. PubMed ID: 32762691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis.
    Wang J; Li P; Wen J
    BMC Health Serv Res; 2020 Jun; 20(1):519. PubMed ID: 32513170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series study.
    Cai L; Tao T; Li H; Zhang Z; Zhang L; Li X
    J Glob Health; 2022 Dec; 12():11016. PubMed ID: 36527382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of DRG on resource consumption of inpatient with ischemic stroke.
    Wei A; Ren J; Feng W
    Front Public Health; 2023; 11():1213931. PubMed ID: 38026323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis.
    Li C; Zhu J; Shan L; Zhou Y; Liu G; Zhu H; Wu Q; Cui Y; Kang Z
    BMC Health Serv Res; 2024 Jan; 24(1):90. PubMed ID: 38233857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of the Full Coverage of Essential Medicines Policy on Utilization and Accessibility of Primary Healthcare Service for Rural Seniors: A Time Series Study in Qidong, China.
    Wang Y; Zhu Y; Shi H; Sun X; Chen N; Li X
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31698773
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of an innovative payment method on medical expenditure, efficiency, and quality for inpatients with different types of medical insurance: evidence from a pilot city, China.
    Lin K; Li Y; Yao Y; Xiong Y; Xiang L
    Int J Equity Health; 2024 Jun; 23(1):115. PubMed ID: 38840102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series.
    Lan T; Guan L; Pang X; Li X; Yu Q
    J Clin Pharm Ther; 2022 Jan; 47(1):104-111. PubMed ID: 34668203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data.
    Yang Y; Zhang Y; Wagner AK; Li H; Shi L; Guan X
    J Glob Health; 2023 Aug; 13():04083. PubMed ID: 37566690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis.
    Huang C; Ung COL; Wushouer H; Bai L; Li X; Guan X; Shi L
    Int J Health Policy Manag; 2022 Aug; 11(8):1489-1495. PubMed ID: 34273922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of national drug price negotiation policy on the accessibility and utilization of PCSK9 inhibitors in China: an interrupted time series analysis.
    Zhang L; Wang X; Yao H; Ding B; Gao X; Li X
    Int J Equity Health; 2024 Jun; 23(1):116. PubMed ID: 38840134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study.
    Zhu D; Shi X; Nicholas S; Bai Q; He P
    BMJ Open; 2019 Aug; 9(8):e029646. PubMed ID: 31401602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrupted time series analysis for the impact of integrated medical insurance on direct hospitalization expense of catastrophic illness.
    Niu L; Song Q; Liu Y; Wang X
    Sci Rep; 2022 Jul; 12(1):12316. PubMed ID: 35854019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
    Rong X; Yin J; Duan S; Sun Q; Babar ZU
    BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impacts of the National Medication Price-Negotiated Policy on the financial burden of cancer patients in Shandong province, China: an interrupted time series analysis.
    Ding Y; Zheng C; Wei X; Zhang Q; Sun Q
    BMC Public Health; 2022 Dec; 22(1):2363. PubMed ID: 36527037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.